Ivan Tortet
Finanzdirektor/CFO bei GENSIGHT BIOLOGICS S.A.
Ursprung des Netzwerks ersten Grades von Ivan Tortet
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 13 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Ivan Tortet
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| X4 PHARMACEUTICALS, INC. | Biotechnology | Chairman Director/Board Member | |
| Universite Paris Cite | College/University | Doctorate Degree Doctorate Degree | |
| Universitat Pompeu Fabra | College/University | Graduate Degree | |
| Ecole Polytechnique | College/University | Undergraduate Degree | |
| CELLECTIS S.A. | Pharmaceuticals: Major | Chief Operating Officer | |
| Neu-Ulm University of Applied Sciences | College/University | Masters Business Admin | |
Priothera SAS
 Priothera SAS BiotechnologyHealth Technology Part of Priothera Ltd., Priothera SAS is a French company dedicated to improving the lives of patients suffering from hematological malignancies by delivering an innovative immune modulator to enhance the curative potential of both allogeneic hematopoietic stem cell transplantation (HSCT) and CAR-T cell therapy. The company is based in Saint-Louis, France. Priothera is leading the way in developing Mocravimod, a S1P receptor modulator as an adjunctive and maintenance immune therapy to allo-HSCT and to CAR-T. Mocravimod has the potential to reduce the occurrence of (acute) GVHD without suppressing T cell function, thus GVL is maintained. Priothera is developing Mocravimod (KRP203) to significantly improve the clinical outcome of allo-HSCT and CAR-T therapy. The company was founded in 2020 by Philippe Lievre, Florent Gros, Brice R. Suire, Stephan Oehen, Simone Seiter. Florent Gros has been the CEO since 2020. | Biotechnology | Founder | |
| Ruprecht-Karls-Universität Heidelberg | College/University | Doctorate Degree | |
| IQVIA | Corporate Officer/Principal | ||
Raptor Pharmaceuticals Europe BV
 Raptor Pharmaceuticals Europe BV Miscellaneous Commercial ServicesCommercial Services Part of Amgen, Inc., Raptor Pharmaceuticals Europe BV is a Dutch company that engages in research and experimental development in other physical and natural sciences. The company is based in Louveciennes, the Netherlands. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| OSE IMMUNOTHERAPEUTICS | Pharmaceuticals: Major | Director/Board Member | |
| Katholieke Universiteit Leuven | College/University | Graduate Degree | |
| RAPTOR PHARMACEUTICAL CORP | Pharmaceuticals: Major | Corporate Officer/Principal | |
Bamboo Therapeutics, Inc.
 Bamboo Therapeutics, Inc. BiotechnologyHealth Technology Bamboo Therapeutics, Inc. develops gene therapy products for central nervous system and neuromuscular diseases. Its therapeutic platform is based on the use of Adeno-associated virus as a gene therapy vehicle. The company’s proprietary technologies include chimeric vectors, self-complementary vectors, and dual glycan receptor. It focuses on the treatment of Duchenne muscular dystrophy, giant axonal neuropathy, Friedreich ataxia, and Canavan disease. Bamboo Therapeutics was founded by Richard Jude Samulski, Sheila A. Mikhail, Josh Grieger, Xiao Xiao, and Paola Leone in December 2014 and is headquartered in Chapel Hill, NC. | Biotechnology | General Counsel | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Standards Coordinating Body | Director/Board Member | ||
StrideBio, Inc.
 StrideBio, Inc. BiotechnologyHealth Technology Stridebio, Inc. focuses on creating and developing novel adeno-associated viral vector technologies. The company was founded by Aravind Asokan, Mavis Agbandje-McKenna and Patrick Ritschel and is headquartered in Durham, NC. | Biotechnology | Corporate Officer/Principal | |
| Advanced Therapies Partners LLC | President | ||
Boston Consulting Group SAS
 Boston Consulting Group SAS Miscellaneous Commercial ServicesCommercial Services Boston Consulting Group SAS operates as a management consulting firm. It provides business and other consultancy services. The company is headquartered in Paris, France. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Suffolk University | College/University | Undergraduate Degree | |
| Bio-Up | Chief Executive Officer | ||
Servier SAS
 Servier SAS Miscellaneous Commercial ServicesCommercial Services Servier SAS is based in Suresnes, France and has a global presence of subsidiaries in several regions. The French company chooses to reinvest its profits in the discovery of new drugs and is recognized for its quality and medical excellence. The company works with patients at all stages of the drug life cycle to provide them with the most suitable care paths. Servier specializes in research on cardiovascular disease, cancer, diabetes, immuno-inflammatory, and neuro-psychiatric diseases. Servier SAS is a pharmaceutical company that was founded in 1954. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Redpin Therapeutics, Inc.
 Redpin Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Redpin Therapeutics, Inc. operates as a biotechnological platform which enables targeted regulation of neuronal activity in brain to achieve treatment and control of CNS circuit and other disorders. The company was founded by Elma S. Hawkins, Jeffrey Friedman, Scott Sternson Michael Kaplitt, Sarah Stanley and Jonathan Dordick in 2017 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Colorado State University | College/University | Undergraduate Degree | |
| Purdue University | College/University | Doctorate Degree | |
| Engineering College | College/University | Undergraduate Degree | |
| University of Oslo | College/University | Graduate Degree | |
| MAUNA KEA TECHNOLOGIES | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| Ecole Polytechnique De L'universite Paris-sud | College/University | Undergraduate Degree | |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Sciences Po | College/University | Graduate Degree | |
| PROQR THERAPEUTICS N.V. | Pharmaceuticals: Major | Corporate Officer/Principal | |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | General Government | Corporate Officer/Principal | |
| Yale Graduate School of Arts & Sciences | College/University | Graduate Degree | |
| Yale University | College/University | Undergraduate Degree | |
Laverock Therapeutics Ltd.
 Laverock Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology Laverock Therapeutics Ltd. develops regenerative medicines for hypo immune pancreatic islet cells and oncology therapeutics. The CEO of the British company is David C. Venables. | Pharmaceuticals: Other | Director/Board Member | |
Wolf-Medizintechnik GmbH
 Wolf-Medizintechnik GmbH Medical DistributorsDistribution Services Wolf-Medizintechnik GmbH provides services in the fields of x-ray technology and electro medicine. It develops and manufactures systems for superficial and orthovoltage x-ray therapy and special systems used in medicine and non-destructive testing. It also distributes diagnostic x-ray equipment and provides technical and maintenance services. The company was founded in 1990 and is headquartered in St. Gangloff, Germany. | Medical Distributors | Director/Board Member | |
| FTI CONSULTING, INC. | Miscellaneous Commercial Services | Director/Board Member | |
| Threefrog Therapeutics | Chairman | ||
METAFORA Biosystems SAS
 METAFORA Biosystems SAS BiotechnologyHealth Technology METAFORA Biosystems SAS is a French company that has received a €3.2 million grant from the European Commission's H2020 SME Instrument program. The company is based in Paris, France. The grant will allow the company to launch a large-scale prospective validation study of the METAglut1 test, which helps in the early diagnosis of De Vivo disease, a rare and under-diagnosed disease. The company has also received exceptional reimbursement for the METAglut1 test. The CEO of the company is Romain Kaspereit. | Biotechnology | Director/Board Member | |
Inova Software SA
 Inova Software SA Packaged SoftwareTechnology Services Inova Software SA develops management software solutions for biopharmaceutical companies. It offers search & evaluation, opportunities tracking, alliance management, mobile access, reporting and security & performance management software solutions. The company was founded by Gilles Toulemonde, Fritz Eisenhart, and David Carteret in 2010 and is headquartered in Villeurbanne, France. | Packaged Software | Director/Board Member | |
Bluestone Venture Partners LLC
 Bluestone Venture Partners LLC Investment ManagersFinance BlueStone Venture Partners LLC (BlueStone Venture Partners) is a venture capital firm founded in 2017 by Mara G. Aspinall and Tom Nickoloff. The firm is headquartered in Tucson, Arizona. | Investment Managers | Consultant / Advisor | |
American Society of Gene & Cell Therapy
 American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services The American Society of Gene & Cell Therapy is a medical and professional organization that represents researchers and scientists devoted to the discovery of gene and cell therapies. The American company was founded by Mark A. Kay. | Miscellaneous Commercial Services | Director/Board Member | |
| Wayne State University (Michigan) | College/University | Undergraduate Degree | |
| Providence College | College/University | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 23 |
| Frankreich | 15 |
| Deutschland | 5 |
| Niederlande | 4 |
| Norwegen | 3 |
Sektoral
| Consumer Services | 18 |
| Health Technology | 17 |
| Commercial Services | 8 |
| Government | 2 |
| Distribution Services | 2 |
Operativ
| Director/Board Member | 38 |
| Corporate Officer/Principal | 24 |
| Independent Dir/Board Member | 17 |
| Director of Finance/CFO | 9 |
| Undergraduate Degree | 8 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Ivan Tortet
- Unternehmensverbindungen
